LOGIN
´ëÇÑôÃßÅëÁõÇÐȸ Á¦38Â÷ Çмú´ëȸ 2022.04.17[ÀÏ] 08:30~17:00 ¿Â¶óÀÎ Çмú´ëȸ
¿Â¶óÀÎ Çà»ç ¸Þ´º¾ó ¿Â¿¡¾î¹öÆ°



4¿ù 17ÀÏ (ÀÏ)

4¿ù 16ÀÏ (Åä)
08:30~08:55 »çÀüÁ¢¼Ó½Ã°£  
08:55~09:00 Opening Address ´ëÇÑôÃßÅëÁõÇÐȸÀå ÀÌÆòº¹
Session I Developing clinical guidelines in real- world practice ÁÂÀå: ¼­¿ï¾Æ»êº´¿ø ½ÅÁø¿ì
09:00-09:25 Guideline development in pain medicine Steven P. Cohen (Johns Hopkins Univ., USA)
09:25-09:50 Clinical guidelines on facet blocks and RF ablation: Extrapolation from the lumbar to cervical Spine Steven P. Cohen (Johns Hopkins Univ., USA)
09:50~10:00 Coffee Break ¡¡
Session II Updates in the modality of spinal pain ÁÂÀå: ¾ç»êºÎ»ê´ëº´¿ø ±è°æÈÆ
ÇѾç´ë±¸¸®º´¿ø ½ÉÀçÇ×
10:00-10:25 New medication
-NSAIDs updates
-Mirogabalin
-Capsaicin, LidocaineÀÇ È°¿ë
¿ø±¤´ëº´¿ø ±è¿¬µ¿
10:25-10:50 New injection drug for spinal intervention
-Other than steroids
ÇØ¿î´ë¹éº´¿ø ÀÌ»óÀº
10:50-11:15 New approach to the epidural space
-Controlateral oblique approach for cervical epidural injection
-Other approaches for thoracic and lumbar level
ºÐ´ç¼­¿ï´ëº´¿ø ÃÖÀºÁÖ
11:15-11:25 Q & A ¡¡
11:25-11:35 Coffee break ¡¡
Session III Address to the new normal ÁÂÀå: ºÐ´ç¼­¿ï´ëº´¿ø ÀÌÆòº¹
11:35-12:25 µ¥ÀÌÅÍ ½ÃÀåÀÇ ÁøÈ­¿Í ÀΰøÁö´ÉÀÇ ºÎ»ó, ±×¸®°í Tesla ±èÁؼº (¸Þ¸®Ã÷Áõ±Ç ¾Ö³Î¸®½ºÆ®)
12:25-13:25 Lunch ¡¡
Session IV Video demonstration of ultrasonography for pain medicine ÁÂÀå: ÀÌ»óö¸¶ÃëÅëÁõÀÇÇаúÀÇ¿ø ÀÌ»óö
°í´ë±¸·Îº´¿ø ÃÖ»ó½Ä
13:25-14:00 USG guided intervention for thoracic pain
-ÈäÃߺΠÅëÁõ Ä¡·á¸¦ À§ÇÑ ÃÊÀ½ÆÄ ½Ã¼úÀÇ È°¿ë
-Áغñ °úÁ¤ ºÎÅÍ ½Ã¼úÀÇ ½ÇÁ¦
¼­¿ï¾Æ»êº´¿ø ±èµÎȯ
14:00-14:35 USG guided intervention for cervical pain
-°æÃߺΠÅëÁõ Ä¡·á¸¦ À§ÇÑ ÃÊÀ½ÆÄ ½Ã¼úÀÇ È°¿ë
-Áغñ °úÁ¤ ºÎÅÍ ½Ã¼úÀÇ ½ÇÁ¦
¼¼ºê¶õ½ºº´¿ø ¹Ú»óÁØ
14:35-14:45 Q & A ¡¡
14:45-14:55 Coffee break ¡¡
Session V Spinal pain in the elderly: What we have to address ÁÂÀå: ¿©Àǵµ¼º¸ðº´¿ø ¼ºÃáÈ£
¹ÚÇмö¸¶ÃëÅëÁõÀÇÇаúÀÇ¿ø ¹ÚÇмö
14:55-15:15 Collagen and exercise in sarcopenia ÀºÆò¼º¸ðº´¿ø ¹®È£½Ä
15:15-15:35 Dangers of polypharmacy in the elderly with spinal pain »ï¼º¼­¿ïº´¿ø ÀÌÁø¿µ
15:35-15:55 Spinal pain in patients with Parkinson's and movement disorder ÇѸ²´ë¼º½Éº´¿ø ½Å°æ°ú ±è¿µÀº
15:55-16:05 Q & A ¡¡
16:05-16:15 Coffee Break ¡¡
Session VI Case presentation: sharing your ideas ÁÂÀå: ±è¿ëö¸¶ÃëÅëÁõÀÇÇаúÀÇ¿ø ±è¿ëö
°í½Å´ëº´¿ø ±èµÎ½Ä
16:15-16:30 Unspecified back pain ÄÛ¸¶ÃëÅëÁõÀÇÇаúÀÇ¿ø ±èȯÈñ
16:30-16:45 Thoracic disc herniation : 2 cases ÀüºÏ´ëº´¿ø µÎ¾Æ¶÷
16:45-17:00 Adverse reactions after erector spinae plane blocks for pain control : 2 cases ÃæºÏ´ëº´¿ø ±èÇöÅÂ
17:00-17:10 Q & A
17:10-17:15 Closing Remark ´ëÇÑôÃßÅëÁõÇÐȸÀå ÀÌÆòº¹


4¿ù 16ÀÏ (Åä)

4¿ù 16ÀÏ (Åä)
08:30-09:00 Registration
09:00-09:10 Opening address ±èµ¿ÀÍ (´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ȸÀå)
09:10-10:40 Free paper session 1 ÁÂÀå: À±»ó¼· (°¡Å縯ÀÇ´ë)
¹Ú»óÁØ (¿ï»êÀÇ´ë)
09:10-09:19 Osteopontin is a key regulator of vascular smooth muscle cell proliferation in the outflow of AVF °í´ë½Ä (°¡ÃµÀÇ´ë)
09:19-09:28 Expression of miRNAs Targeting ABCA1 Among Patients with Significant Carotid Artery Stenosis Á¤¼±Á¤ (¿ï»êÀÇ´ë)
09:28-09:37 Electrospun graft from PCL/ decellularized ECM hybrid polymer for small-caliber vascular application ÇѾƶ÷ (¼­¿ïÀÇ´ë)
09:37-09:46 Prospective observational study of treatment in symptomatic C1 patients with saphenous vein reflux Á¶¾Æ¶ó (¼­¿ïÀÇ´ë)
09:46-09:55 Lung cancer as a risk factor for abdominal aortic aneurysm ±ÇÁؼº (ÂüÇÏÁö¿Ü°ú)
09:55-10:04 The impact of introducing a hybrid operating room on the hybrid vascular procedure. ½Å¿µÈç (¼­¿ïÀÇ´ë)
10:04-10:13 Characteristics of Korean patients with venous thromboembolism compared to Western population ±èÁö¼± (Bayer Korea)
10:13-10:22 Clinical outcomes of non-thermal ablation, thermal ablation, & surgical stripping for varicose vein Á¶¼º½Å (°æÈñÀÇ´ë)
10:22-10:31 Comparison between RFA for vein removal and CHIVA strategy to preserve veins À±»óö (¼øõÇâÀÇ´ë)
10:31-10:40 Outcomes of Surgically Treated Arteriovenous Fistula Aneurysm in Patients on Regular Hemodialysis Á¶¼º½Å (°æÈñÀÇ´ë)
10:40-11:00 Coffee Break
11:00-12:00 Symposium 1 - What¡¯s new in the vascular world ÁÂÀå: Á¶ÁøÇö (°æÈñÀÇ´ë)
°­Áø¸ð (°¡ÃµÀÇ´ë)
11:00-11:15 K-DOQI guideline updates: What is the life-plan for ESRD patients? ±èÇâ°æ (¿ï»êÀÇ´ë)
11:15-11:30 Is IVUS highly recommended for PAD intervention? TBD
11:30-11:45 Recent updates in NOAC - new indications ÇѾƶ÷ (¼­¿ïÀÇ´ë)
11:45-12:00 Changes in visceral aneurysm management guidelines ȲÁ¤±â (°¡Å縯ÀÇ´ë)
12:00-12:30 ȸÀå°­¿¬ ÁÂÀå: ÀåÀÌÂù (ÃæºÏÀÇ´ë)
12:00-12:30 Ç÷°ü¿Ü°ú ÀÇ»çÀÇ ±æ ±èµ¿ÀÍ (¼º±Õ°üÀÇ´ë)
12:30-13:30 Luncheon ÁÂÀå: ±èÇü±â (°æºÏÀÇ´ë)
12:30-13:00 Heli-FX Endoanchor 5Yrs Registry I-Hui Wu (National Taiwan University Hospital, Taiwan)
13:00-13:30 ENGAGE 8Yrs Vincent Riambau (Teknon Medical Center, Spain)
13:30-15:00 Free Paper Session 2 ÁÂÀå: Á¶¿ëÇÊ (¿ï»êÀÇ´ë)
¾ÈÇüÁØ (°æÈñÀÇ´ë)
13:30-13:39 Late open surgical conversion after endovascular aortic aneurysm repair: A 20-year experience ¹Ú¾çÁø (¼º±Õ°üÀÇ´ë)
13:39-13:48 The Uncomfortable Truth on Outcomes Related to Ruptured Abdominal Aortic Aneurysm in Korea Á¶Àº¾Æ (¼­¿ïÀÇ´ë))
13:48-13:57 Comparison of treatment outcomes based on risk stratification in carotid revascularization ¹ÚÁرâ (¼º±Õ°üÀÇ´ë)
13:57-14:06 Duplex ultrasound findings and clinical outcomes of carotid restenosis after carotid endarterectomy À念Áø (¿ï»êÀÇ´ë)
14:06-14:15 Clinical outcomes of hypogastric artery interruption during endovascular aneurysm repair ±èÇöÁÖ (°æºÏÀÇ´ë)
14:15-14:24 The Feasibility of Fenestrated EVAR from Korean single institution data base Çö»óÈ£ (¼­¿ï¼º¸ðº´¿ø)
14:24-14:33 Clinical characteristics affecting the treatment outcome of pseudoaneurysms after femoral access Á¤ÇüÀº (ÀüºÏÀÇ´ë)
14:33-14:42 Can prosthetic grafts be an alternative option for below knee bypass? ±è¿µÇý (°æºÏÀÇ´ë)
14:42-14:51 Outcomes of CEA compared between primary and patch closure; using propensity score matching analysis ±è¹Î±Ô (¼º±Õ°úÀÇ´ë)
14:51-15:00 Effect of angioplasty on sarcopenia in PAOD patients ±èµ¿Çö (ºÎ»êÀÇ´ë)
15:00-16:00 Symposium 2 - Challenges in AAA treatment ÁÂÀå: ¹Ú±âÇõ (´ë±¸°¡Å縯ÀÇ´ë)
¹Ú¾çÁø (¼º±Õ°üÀÇ´ë)
15:00-15:15 Has EVAR been satisfactory? Open repair is to be revisited for hostile anatomy ¾È»óÇö (¼­¿ïÀÇ´ë)
15:15-15:30 PAU or IMH as new indications for endovascular treatment Á¤ÇõÀç (ºÎ»êÀÇ´ë)
15:30-15:45 T-branch/P-branch for TAAA Bijan Modarai (King¡¯s College London, United Kingdom)
15:45-16:00 Does EndoAnchor help widen the indications for EVAR with hostile neck? ¹ÚÀÇÁØ (°è¸íÀÇ´ë)
16:00-16:20 Coffee Break
16:20-17:20 Poster Presentation ÁÂÀå: Á¤Àθñ (¼­¿ïÀÇ´ë)
¾È¹®»ó (Ãæ³²ÀÇ´ë)
16:20-16:27 PostCyanoacrylate Allergic Reaction(PoCAR) after cyanoacrylate closure operation for varicose vein ±è´ëÁß (ºÎ»êÀÇ´ë)
16:27-16:34 Complications and Mid-term Results after Isolated Endarterectomy of the Femoral Bifurcation ¹Ú¼öÇö (°æºÏÀÇ´ë)
16:34-16:41 Risk factor of iliac artery rupture during aortoiliac artery stenting À̱¤Áø (°æÈñÀÇ´ë)
16:41-16:48 Do more abdominal aortic aneurysm surgeries result in fewer postoperative complications? ¹ÚÁ¦Çü (ºÎ»êÀÇ´ë)
16:48-16:55 Femoral endarterectomy with combined infrainguinal revascularization in multi-level arterial disease ¹Ú¼öÇö (°æºÏÀÇ´ë)
16:55-17:02 À̹ÌÁö ±â¹Ý µö·¯´×À» È°¿ëÇÑ Ç¥Àç´ëÅðµ¿¸Æ Áúȯ ºÐ·ù ÀÌ¿ä¼Á (¼­¿ï¼º¸ðº´¿ø)
17:02-17:09 Prevalence and characteristics of superior mesenteric artery abnormalities by reviewing CT scan À¯±Çö (ÃæºÏÀÇ´ë)
17:09-17:13 ¹ß »óó¸¦ µ¿¹ÝÇÑ ÁßÁõÇÏÁöÇãÇ÷ ȯÀÚ¿¡¼­ TcPO2¸¦ ÀÌ¿ëÇÑ ÀÓ»ó°æÇè ¿ì¿µÁ¦ (°Åⱺº¸°Ç¼Ò)
17:13-17:20 Clinical events analysis of venoactive drugs using the big data from the National Health Insurance Á¶ÁøÇö (°æÈñÀÇ´ë)
17:20-17:50 ¿¬±¸ÀåÇÐ±Ý º¸°í ÁÂÀå: Çã½Â (°æºÏÀÇ´ë)
17:20-17:35 2019³â ÀÌ¿ë°¢ ¿¬±¸ÀåÇÐ±Ý (±âÃʺι®) ¼öÇýº¸°í ¾ÈÇüÁØ (°æÈñÀÇ´ë)
17:35-17:50 2019³â ÀÌ¿ë°¢ ¿¬±¸ÀåÇÐ±Ý (ÀÓ»óºÎ¹®) ¼öÇýº¸°í Á¶ÁøÇö (°æÈñÀÇ´ë)
17:50-18:00 Award and Closing remarks ±èµ¿ÀÍ (´ëÇÑÇ÷°ü¿Ü°úÇÐȸ ȸÀå)

* ¸ðµç Âü¼®ÀÚ Ã¼¿Â ÃøÁ¤ ¿¹Á¤ * ¸¶½ºÅ© ¹ÌÂø¿ëÀÚ ÃâÀÔ ºÒ°¡